To further validate the observed upregulation of FOXP1‐transition B cells in the PBMCs of type 1 AIP patients, we collected and analyzed PBMC samples from five individuals diagnosed with type 1 AIP and five healthy donors. This evidence concerns the gene FOXP1 and autoimmune pancreatitis type 1.